Klotho Neurosciences Inc
NASDAQ:GRML
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Klotho Neurosciences Inc
NASDAQ:GRML
|
US |
|
Lithium Australia NL
ASX:LIT
|
AU |
|
N
|
Namuga Co Ltd
KOSDAQ:190510
|
KR |
|
A
|
Apollomics Inc
NASDAQ:APLM
|
US |
|
F
|
Fabled Silver Gold Corp
OTC:FBCPF
|
CA |
|
S
|
SynBiotic SE
XMUN:SBX
|
DE |
|
T
|
Temas Resources Corp
F:26P
|
CA |
|
E
|
Euro Manganese Inc
F:E06
|
CA |
|
EPH European Property Holdings Ltd
F:E6P
|
VG |
|
T
|
Triumph Gold Corp
LSE:0VLY
|
CA |
|
Bachem Holding AG
F:BHM0
|
CH |
|
A
|
Addvalue Technologies Ltd
SWB:DDU
|
SG |
|
SmartKem Inc
NASDAQ:SMTK
|
UK |
|
T
|
Taiwan Benefit Co
TPEX:3379
|
TW |
Bankruptcy Probability
Klotho Neurosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Klotho Neurosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Klotho Neurosciences Inc
NASDAQ:KLTO
|
32.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
442.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
64.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Klotho Neurosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Klotho Neurosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
